Post‑Transplant, HIV‑1 RNA, Real‑Time PCR, Plasma
Also known as: Specialized, Services, HIV Viral Load, PTxplnt, Txplnt
Use
This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV‑1 infected patients. It can be used to assess patient prognosis by measuring the baseline HIV‑1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV‑1 RNA levels during the course of treatment. Reportable range is 20 to 10,000,000 copies/mL (1.30‑7.00 Log copies/mL).
Special Instructions
Setup schedule: sets up 7 days a week.
Limitations
Not provided.
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
3 mL
Minimum Volume
1 mL
Container
EDTA (lavender‑top) tube
Causes for Rejection
Samples frozen in primary tube • Unspun whole blood samples >24 hours from collection • Samples collected in sodium or lithium heparin • Frozen whole blood
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 6 days |
| Frozen | 84 days |